Acute Monocytic Leukemia — knowledge graph · CancerIndex

Knowledge graph · Cancer

Acute Monocytic Leukemia

hematologic malignancy

Identifier: CI-CAN-00008646
Entity page: /cancer/acute-monocytic-leukemia ↗
Edges: 125

Neighbours: 40 drugs10 trials
Drawn: 50 of 50 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Acute Monocytic Leukemia investigated in trials for …INVESTIGATED_IN_TRIALSderived40 of 40show fewer
→ investigated in trials for	Cytarabinesmall molecule 33 trials (2 active) · roll-up of the cancer and its descendants	—	—	Acute Monocytic Leukemia	33	Observed	clinicaltrials	graph →
→ investigated in trials for	Etoposidesmall molecule 13 trials (0 active) · roll-up of the cancer and its descendants

Acute Monocytic Leukemia studied in …STUDIED_INderived10 of 85show all (up to 200)
→ studied in	NCT06504459Phase 2 · recruiting Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML · condition mapped ONTOLOGY_EXACT · 85 trials mapped (9 active)	—	—	Acute Monocytic Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT05282459Phase 1/Phase 2 · completed Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation · condition mapped ALIAS · 85 trials mapped (9 active)	—	—	Acute Monocytic Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT02071901Phase 2 · completed Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy · condition mapped ONTOLOGY_EXACT · 85 trials mapped (9 active)	—	—	Adult Acute Monocytic Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT00093470Phase 3 · completed Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission · condition mapped ONTOLOGY_EXACT · 85 trials mapped (9 active)	—	—	Adult Acute Monocytic Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT00658814Phase 2 · active not recruiting Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 85 trials mapped (9 active)	—	—	Adult Acute Monocytic Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT07292272NA · recruiting Halt Aging in Survivors of Blood Cancers · condition mapped ALIAS · 85 trials mapped (9 active)	—	—	Acute Monocytic Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT01627041Phase 2 · active not recruiting Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 85 trials mapped (9 active)	—	—	Adult Acute Monocytic Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT07512700Phase 2 · recruiting Venetoclax Combined With CACAG Regimen Versus "3+7" Regimen in the Treatment of Acute Monocytic Leukemia · condition mapped ONTOLOGY_EXACT · 85 trials mapped (9 active)	—	—	Acute Monocytic Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT06950034Phase 1 · recruiting A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML) · condition mapped ONTOLOGY_EXACT · 85 trials mapped (9 active)	—	—	Acute Monocytic Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT06429449Phase 1 · recruiting Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia · condition mapped ALIAS · 85 trials mapped (9 active)	—	—	Acute Monocytic Leukemia	1	Observed	clinicaltrials	graph →